COMMUNIQUÉS West-GlobeNewswire

Tetra Bio-Pharma Pursues Its Research Priorities Accelerating Other Drug Development Plans
07/02/2019
Last Week’s Agreement to Acquire PANAG Establishes Exhaustive Dermatology and Ophthalmic Product Portfolios ORLEANS, Ontario, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") ( [...]
Avadel Pharmaceuticals Clarifies Announcement of Corporate Restructuring
07/02/2019
DUBLIN, Ireland, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL) provided clarification regarding the restructuring actions announced earlier today. As part of the restructuring plan, Avadel [...]
The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Seventh Annual Cell & Gene Therapy Investor Day
07/02/2019
WASHINGTON, D.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today announced the initial slate of presenting companies at its annual Cell & Gene Therapy [...]
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
07/02/2019
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 7 février 2019 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
OSE Immunotherapeutics and Servier Announce First Option Within Global License Agreement Exercised for Further Clinical Development and Potential Commercialisation of OSE-127 in Autoimmune Diseases
07/02/2019
Servier exercised first of two steps under OSE-127 global licensing option agreement OSE-127, an IL-7R antagonist, is currently in Phase 1 clinical testing NANTES, France and PARIS, Feb. 07, 2019 (GLOBE NEWSWIRE) -- OSE [...]
Vital® Spotlights True Interoperability at HIMSS 2019 and Celebrates a KLAS No. 1 Ranking for Advanced Visualization
07/02/2019
MINNETONKA, Minn., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Vital, a Canon Group company, will demonstrate its powerful Vitrea ® Enterprise Imaging solution at this year's Healthcare Information and Management Systems Society [...]
Emergent BioSolutions to Release Fourth Quarter and Full Year 2018 Financial Results and Conduct a Conference Call on February 21, 2019
07/02/2019
GAITHERSBURG, Md., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 21, 2019 at 5:00 pm (Eastern Time) to discuss the financial results for the [...]
Coherus BioSciences Announces New Employment Inducement Grants
07/02/2019
REDWOOD CITY, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective February 6, 2019, the compensation committee of the company’s board of directors granted [...]
Vystar to Resume Production of Rx3000 UV Light Air Purifiers for Use in Hospitals, Healthcare Facilities
07/02/2019
Destroys on first pass more than 99.97% of harmful airborne viruses and bacteria. Inactivates pathogens that cause measles, the common cold, MRSA (staph), whooping cough, TB, pneumonia and other antibiotic-resistant and [...]
BioAegis Therapeutics Expands Phase 1b/2a Community-Acquired Pneumonia Study to the Republic of Georgia —Successfully Completes Second of Four Dosing Cohorts
07/02/2019
MORRISTOWN, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that patient enrollment is underway in a Phase 1b/2a study of recombinant plasma gelsolin (rhu-pGSN) in Community-Acquired [...]
Nemaura Medical Announces Grant of U.S. Patent for SugarBEAT® Glucose Sensing Algorithm
07/02/2019
Loughborough, England – February 7, 2019 – Nemaura Medical Inc. (NASDAQ: NMRD) nemauramedical.com , a medical technology company focused on the development of SugarBEAT® as a non-invasive, affordable and flexible [...]
Third Study Verifies Milestone Scientific’s CompuFlo® Instrument Differentiates False Loss of Resistance During Epidural Blocks
07/02/2019
Easier, more reliable identification essential to reducing failed epidurals and complications LIVINGSTON, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) today announced a new 120-patient [...]
NewLink Genetics to Host Its Fourth Quarter and Full Year 2018 Financial Results Conference Call on February 27, 2019
07/02/2019
AMES, Iowa, Feb. 07, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will release its fourth quarter and full year 2018 financial results on Wednesday, February 27, 2019. The [...]
Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations
07/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and simple-to-use tissue image analysis [...]
Devimistat (CPI-613®) to be Explored in a New Combination for T-Cell Lymphoma Treatment as Part of Stand Up To Cancer’s T-Cell Lymphoma “Dream Team Research Grant”
07/02/2019
This study will be conducted under the ‘Tailoring CAR-based immunotherapy strategies to T-Cell Lymphoma’ project Newark, NJ, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a [...]
Precision Therapeutics’ Skyline Medical Division Expands Presence in Australia with Three New STREAMWAY Systems at Wangaratta Hospital in Victoria
07/02/2019
MINNEAPOLIS, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announces its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY [...]
Innovate Biopharmaceuticals Announces Presentation at BIO CEO & Investor Conference
07/02/2019
Presentation will Highlight Progress in Celiac Disease Phase 3 Trial Timeline and NASH RALEIGH, N.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT) a clinical stage biotechnology [...]
Fluidigm Announces Participation in Life Science/Pharma and Academic Consortium to Study T Cell-Driven Immune-Mediated Inflammatory Diseases
07/02/2019
Gaining insights into inflammatory bowel disease through mass cytometry and Imaging Mass Cytometry analysis of the human mucosal immune system Research aimed at more precise treatments for IMIDs using existing therapies [...]
Aleafia Health Helps Patients & Investors with Revenue Generating Research -- CFN Media
07/02/2019
SEATTLE, Wash., Feb. 07, 2019 (GLOBE NEWSWIRE) -- -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces [...]

Pages